Commitment Point during G0→G1 That Controls Entry into the Cell Cycle
CD4-Positive T-Lymphocytes
570
0303 health sciences
CD3 Complex
Recombinant Fusion Proteins
Cell Cycle
G1 Phase
610
Cell Differentiation
Cell Separation
CD8-Positive T-Lymphocytes
Lymphocyte Activation
Resting Phase, Cell Cycle
Antibodies
03 medical and health sciences
CD28 Antigens
Gene Products, tat
Humans
Interleukin-2
Enzyme Inhibitors
Mitogens
Cell Division
Cells, Cultured
Cyclin-Dependent Kinase Inhibitor p16
DOI:
10.1128/mcb.23.7.2351-2361.2003
Publication Date:
2003-03-15T12:41:05Z
AUTHORS (8)
ABSTRACT
Initiation of T-lymphocyte-mediated immune responses involves two cellular processes: entry into the cell cycle (G(0)-->G(1)) for clonal proliferation and coordinated changes in surface and secreted molecules that mediate effector functions. However, a point during G(0)-->G(1) beyond which T cells are committed to enter the cell cycle has not been defined. We define here a G(0)-->G(1) commitment point that occurs 3 to 5 h after CD3 and CD28 stimulation of human CD4 or CD8 T cells. Transition through this point requires cdk6/4-cyclin D, since inhibition with TAT-p16(INK4A) during the first 3 to 5 h prevents cell cycle entry and maintains both naive and memory T cells in G(0). Transition through the G(0)-->G(1) commitment point is also necessary for T cells to increase in size, i.e., to enter the cellular growth cycle. However, transition through this point is not required for the induction of effector functions. These can be initiated while cells are maintained in G(0) with TAT-p16(INK4A). We have termed this quiescent, activated state G(0(A)). Our data provide proof of the principle that entry of T cells into the cell cycle and cellular growth cycles are coupled at the G(0)-->G(1) commitment point but that these processes can be uncoupled from the early expression of molecules of effector functions.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (62)
CITATIONS (80)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....